Univ.-Prof. Dr. Dr. Eva Schulte
- Since 2023-W2 Professor & Division Head Psychiatric Genomics, Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany
- Since 2020-Group leader, Institute of Psychiatric Phenomics and Genomics, University of Munich, Munich, Germany
- Since 2022-Board certification Psychiatry & Psychotherapy
- Since 2019-Board certification Neurology
- 2016 to 2023-Resident, Department of Psychiatry and Psychotherapy, University of Munich, Munich, Germany
- 2009 to 2014-Resident, Department of Neurology, Klinkum rechts der Isar, Technical University of Munich and Institute of Human Genetics, Helmholtz Munich, Munich, Germany
- 2022-2023-Visiting Research Fellow, Wellcome Sanger Institute, Hinxton, UK
- 2022-Habilitation, University of Munich, Munich, Germany
- 2014-Visiting Postdoctoral Fellow, Stanford University, Palo Alto, CA, USA
- 2013-PhD, Technical University of Munich, Munich, Germany
- 2012-2013-Visiting PhD Student, Duke University, Durham, NC, USA
- 2010-Medical Doctorate, University of Freiburg, Freiburg, Germany
- 2006-Visiting Undergraduate Student, Brigham & Women's Hospital & Harvard Medical School, Boston, MA, USA
- Psychiatric genetics (association studies, polygenic risk)
- Functional annotation using high-throughput screens
- Lipidomics & other “-omics” modalities
- Genetic diagnostics in psychiatry
- Bipolar & Depressive Disorder
- Psychoses & Schizophrenia
- Genetic counseling in neuropsychiatric disorders
- Graduate Student Award, Helmholtz Munich 2014 (for best PhD thesis 2013/2014)
- American Society for Human Genetics/Charles J. Epstein Trainee Award for Excellence 2013 (semifinalist, pre-doctoral)
- for numerous national and international journals such as JAMA Psychiatry and Molecular Psychiatry
Memberships & Offices
- International Society for Psychiatric Genetics (ISPG; Genetic Testing Committee 2017 to 2020)
- American Society for Human Genetics (ASHG)
- National Pandemic Cohort Network (NAPKON) & Network University Medicine (NUM) (FOSA Human Genetics, co-spokesperson)
- German Society for Psychiatry, Psychotherapy and Neurology (DGPPN; section "Genetic, Molecular and Cellular Neuroscience")
- by the German Research Foundation (DFG), the State of Bavaria and various foundations as well as intramural funds (1.2 million Euros own share of the total third-party funding volume)
- Tkachev A*, Stekolshchikova E*, Vanyushkina A, ..., Schulte EC*, Khaitovich P*. Lipid Alteration Signature in the Blood Plasma of Individuals With Schizophrenia, Depression, and Bipolar Disorder. JAMA Psychiatry 2023, 80(3):250-259.
- Kalman JL, Burkhardt G, Adorjan K, ..., Schulte EC. Biobanking in everyday clinical practice in psychiatry-The Munich Mental Health Biobank. Front Psychiatry. 2022, 13:934640. PMID: 35935431 (IF 2021: 5.4).
- Niemi MEK, Karjalainen J, Liao RG, ..., Schulte EC, et al. Mapping the human genetic architecture of COVID-19. Nature 2021, 600(7889):472-477.
- Mullins N, Forstner AJ, O'Connell KS ..., Schulte EC, et al. Genome-wide association study of over 40,000 bipolar disorder cases provides new insights into the underlying biology. Nat Genet 2021, 53(6):817-829.
- Wray NR, Ripke S, Mattheisen M, ..., Schulte EC, et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat Genet 2018, 50, 668-681.
- Schulte EC*, Kousi M*, Tan PL, et al. Targeted resequencing and systematic in vivo functional testing identifies rare variants in MEIS1 as significant contributors to restless legs syndrome. Am J Hum Genet 2014, 95:85-95.
- Schulte EC, Knauf F, Kemlink D, et al. Variant screening of the coding regions of MEIS1 in patients with restless legs syndrome. Neurology 2011,76:1106-1108.